Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?

The TWEAK/Fn14 pathway is now well-known for its involvement in the modulation of inflammation in various human autoimmune/chronic inflammatory diseases (AICID) including lupus, rheumatoid arthritis, and multiple sclerosis. A panel of data is now available concerning TWEAK expression in tissues or b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertin, Daniel, Stephan, Delphine, Khrestchatisky, Michel, Desplat-Jégo, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873518/
https://www.ncbi.nlm.nih.gov/pubmed/24409182
http://dx.doi.org/10.3389/fimmu.2013.00489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873518/
https://www.ncbi.nlm.nih.gov/pubmed/24409182
http://dx.doi.org/10.3389/fimmu.2013.00489

Ejemplares similares